Congress is currently debating the federal research budget—and funding for biomedical research, including urologic science, is at risk. While this action specifically supports kidney and bladder cancer research, the broader message is clear: all federal funding …
Uncategorized
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required) This Notice of Funding Opportunity (NOFO) encourages the submission of pilot and feasibility clinical trials conducted in humans that will lay the foundation for larger clinical trials related to the prevention and/or treatment of diseases and conditions within the mission of NIDDK. [Posted on 1/8/2025. Expires 5/8/2026]
CAIRIBU Investigators at the 2025 SoBPD Meeting
See more information and all CAIRIBU affiliated investigators presenting at the upcoming 2025 Society of Benign Prostatic Disease (SoBPD) Meeting on February 7th-8th, 2025 in Orlando, Florida. Register by January 16 to receive the discounted rate.
Stanford University – Stanford Center for Clinical and Translational Research and Education (Spectrum) Funding
See all funding opportunities from Stanford University.
Duke University Welcomes Dr. Wilkins to KURe – K12 Program
Natasha Wilkins, PhD, a preclinical scientist with over ten years of research experience in rodent models of spinal cord injury, was recently appointed as a CAIRIBU K12 Scholar in the KURe Program at Duke University.
Dr. Penniston and Dr. Vezina Coordinate KUH Symposium
On August 3-4, 2023, Kristina Penniston, PhD, RDN, and Chad Vezina, PhD hosted over 150 students and faculty members affiliated with NIDDK-funded R25 undergraduate research programs from 12 institutions across the country.